Highly Conformal, Hypofractionated, Focally Dose Escalated Post-Prostatectomy Radiotherapy

Radiation will be delivered at an escalated dose to areas of recurrent prostate cancer identified on imaging and a reduced dose will be delivered to the entire prostate bed.

Radiation will be delivered to the prostate bed only.

At screening, if required by clinician.

At screening, if required by clinician.

Computed tomography of the abdomen and pelvis if clinically indicated at screening, with oral and intravenous contrast.

mpMRI of the prostate bed at screening and 6 month follow up.

After enrollment if clinically indicated (i.e., anti-androgen, gonadotropin releasing hormone agonist, or combination of both).